Verastem, Inc. (VSTM) Social Stream

Verastem, Inc. (VSTM): $2.94

0.06 (+2.08%)

POWR Rating

Component Grades













Add VSTM to Watchlist
Sign Up

Industry: Biotech


of 502

in industry

Featured Post From StockTwits About VSTM

$VSTM Verastem is very well positioned to be acquired. It has a "necessary" drug. Consensus among those in the know is that huge DATA is due. I acquiesce, and will go one more to say it puts them in a power position in a "Buyout". Receivables, (330M deal with royalties), Strong Pipeline, FDA Breakthrough Designation, (which is noteworthy, especially now), and Cash Runway till 2024, plus CASH. What's not to love. This is not a $3 stock.
Suitor are in wait.
ChartHawk, published August 4, 2021

What Else are VSTM Traders Talking About?

Other tickers frequently mentioned alongside VSTM is SAVA.

Other Notable StockTweets About VSTM

$VSTM Can Verastem VSTM have a strong upward price move ... ?
Here is an example - Cassava Sciences - $SAVA
Here is SAVA Price & Volume Chart since September 2020 ...
January to February 2021 from $10 to over $100
in April 2021 back down to low $30's
April 2021 to July 2021 back up to $100 to $120 / share ...
@LonoTrader @TMessi @CrozrX

Alt_Fuel, published July 27, 2021

$VSTM Resistance levels that need to be dealt with. We need 10 min closes above 3.56, 3.62 and 3.70. Getting above, and staying above 3.62 today is a good aggressive goal.

1baddude2, published July 16, 2021

$VSTM If the Baker Boys and the like are here, the only reason it would pull back hard off $5, is they know the Tutes are coming in on the walls, and they are collecting more. This is not a $3.77 stock. Significant Cash Runway, 330M deal with residuals, FDA ODD Granted, pipeline & future revenue = $20-$50 easily. This is artificially depressed. Not even at intrinsic. LOAD WITH CONFIDENCE.

ChartHawk, published July 9, 2021

$VSTM It is really easy to get distracted by the daily gyrations of bios, VSTM included. Consider how many new inexperienced Robinhood day-traders, algos, and MM's manipulate the price. None of this has anything to do with future success or commercial viability. That volatility tends to express across the entire universe of start-ups, so try not to get too wigged out.

JCMV, published July 3, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5037 seconds.